Europe Infusion Pump Market

The report "Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-Dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031" is projected to reach USD 7.09 billion by 2031 from USD 5.11 million in 2026, growing at a CAGR of 6.8%.

Browse 280 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-Dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-infusion-pump-market-4352938.html

The rapid expansion of the Europe infusion pump market is driven by several key factors, including technological advancements, evolving healthcare delivery models, and demographic shifts across the region. The introduction of sophisticated, interconnected infusion systems has been transformative, with these devices increasingly integrating with electronic health records (EHRs) and hospital IT infrastructures widely used in European healthcare systems. This integration supports precise dosing, enables real-time monitoring, and enhances clinical decision-making, improving patient safety while streamlining workflows for healthcare providers.

Regulatory authorities in Europe are intensifying their focus on patient safety, interoperability, and cybersecurity standards for infusion pumps, particularly under frameworks such as the EU Medical Device Regulation (MDR). Given the critical role these devices play in administering a wide range of medications, stringent regulatory requirements are in place to mitigate risks from medication errors and cybersecurity vulnerabilities. Another significant driver of market growth is the shift of treatment delivery from hospital settings to homecare and ambulatory settings, especially for chronic conditions such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders. This trend is closely linked to Europe’s aging population, which has a higher prevalence of chronic illnesses and increasingly favors home-based care for long-term disease management. Collectively, these factors are reshaping the infusion therapy landscape in Europe, underscoring the convergence of technological innovation, regulatory evolution, and patient-centric care models.

By type, the accessories & consumables segment accounted for the largest market share in 2025.

In 2025, the accessories & consumables segment by type held a larger share of the Europe infusion pump market. The major share attributed to infusion pump disposables is linked to their indispensable role in the safety and effectiveness of healthcare medication administration in Europe. This segment includes essential components such as infusion sets, catheters, tubing, and connectors, most of which are single-use products and thus require frequent replacement to ensure patient safety and minimize the risk of healthcare-associated infections. Market demand is strongly driven by the need for regular replenishment. In addition, the high prevalence of chronic diseases in Europe, such as diabetes, cancer, and autoimmune diseases, has led to increased use of infusion therapies, which in turn has raised demand for disposable accessories. As a result of the extensive use of infusion pumps in hospitals, home care, and ambulatory care centers across Europe, there remains a strong need for high-quality, compatible accessories, which is driving the segment's continued growth.

By application, the diabetes management segment is expected to grow at the highest CAGR in the market during the forecast period.

The diabetes management segment of the infusion pump market in Europe will grow at the highest CAGR during the forecast period. Rising incidence of diabetes and rapid innovation in insulin infusion technology in Europe are major drivers of this segment. A major factor fuelling this segment is a trend toward the most advanced insulin delivery technologies, especially hybrid closed-loop systems and automated insulin delivery systems, which enable an immediate change in the insulin infusion rate based on glucose concentration.

In Europe, increased access to insulin pumps with simpler interfaces, more advanced touch screens, improved basal infusion rate management, and mobile connectivity has made patients more comfortable, leading to better therapy adherence. In addition, demographic shifts, including an aging population, lifestyle factors, and rising obesity rates, have all contributed to a growing pool of diabetic patients, driving demand for insulin infusion pumps at an accelerated rate and sustaining a positive trend in application.

Don’t miss out on business opportunities in Keyword. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/